rescheduling
Consumers encouraged to talk to pharmacists on delistings: NPS
As the end of 2015 nears, NPS MedicineWise has joined other stakeholders in encouraging Australians who are prescribed OTC medicines to talk to their pharmacists and doctors about how the …
TGA seeks submissions on codeine options
The TGA is seeking further advice and submissions from stakeholders in regard to newly proposed options for the future scheduling of OTC codeine-containing preparations. Last month it deferred its final …
Be ready for 2016 changes: Quilty
As 2016 looms, community pharmacies need to be prepared for the optional $1 script copayment discount, and the delisting of several medicines from the PBS, Guild executive director David Quilty …
Codeine rescheduling delay causing harm: ScriptWise
The TGA decision to defer the rescheduling of codeine-containing OTC medications conflicts with rising codeine analgesics misuse, its devastating consequences and the recognition that opioid misuse is a public health …
Time allows Regulation Impact Statement on codeine: PSA
The Pharmaceutical Society of Australia has welcomed the deferral of a final decision on the possible rescheduling of codeine. PSA National President, Joe Demarte says that the extra time allowed …
Stakeholders gear up on real-time codeine monitoring
The deferment of a final decision on the upscheduling of codeine-containing OTCs is very good news, but stakeholders now need to get moving quickly on the proposed real-time monitoring system …
Guild welcomes codeine decision deferment
The Pharmacy Guild of Australia has welcomed today’s decision to defer the proposed re-scheduling of medicines containing codeine until 2017, subject to further consideration. The delegate of the Secretary of …
Codeine stays OTC… for now
Over-the-counter medicines containing codeine will remain OTC until at least 2017, the TGA has announced. A delegate of the Secretary to the Department of Health gave notice of the deferment …
Upscheduling codeine could have migraine silver lining
There’s been a lot of debate on upscheduling codeine, writes Phil Spyrou, but if it happens, pharmacists will have an opportunity to help migraine sufferers The final decision on whether …
Why upscheduling codeine combination products is a really bad idea
Professor Peter Carroll, Dr Rebekah Moles, Dr Slade Matthews, Stuart Nankivell and Nick Logan (Members of the NSW Poisons Advisory Committee) on why they think upscheduling combination codeine products is …
Why it’s hard to justify upscheduling codeine OTCs: Schoombie
As the final decision on OTC codeine scheduling draws near, ASMI’s Deon Schoombie ponders some of the drawbacks of upscheduling In the lead up to the announcement of the final …
Survey to probe codeine sales restrictions impact
A University of Tasmania research project will seek to understand how codeine sales restrictions will affect codeine consumers and health professionals and are asking affected people to answer a questionnaire. …